ArticleBMJ open2020

Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcome.

Renly Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.